Innovative, high-quality medical education for clinicians in cardiology and other specialties.
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP
Pauline A. Swift, PhD
CETP Inhibition: A Class Reborn
Christie Ballantyne, MD
Erin Michos
Obicetrapib: Mechanism Meets Clinical Impact
Efficacy and Safety Deep Dive What Latest Data Tell Us
What Comes Next: Building the Future Lipid Toolbox
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Philip Scheltens, MD, PhD
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load